Fractyl Health

Fractyl Health, Inc. (Nasdaq: GUTS) is a clinical-stage metabolic therapeutics company developing treatments that target the root causes of type 2 diabetes and obesity rather than managing symptoms. Its lead product, Revita, is an outpatient endoscopic procedure that resurfaces the duodenal lining to address a driver of metabolic disease, and Rejuva is an early-stage pancreatic islet-cell gene therapy platform designed for durable, one-time metabolic remission. The company is headquartered in Massachusetts and backed by Bessemer Venture Partners and General Catalyst. Fractyl publishes no public developer API, SDK, or developer portal; this API Evangelist profile tracks its corporate, product, and investor web presence.

Fractyl Health is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Metabolic Therapeutics, and Type 2 Diabetes.

Fractyl Health’s developer surface includes support and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

10.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyHealthcareBiotechnologyMetabolic TherapeuticsType 2 DiabetesObesityGene TherapyMedical Devices

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 10.0/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.8 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/fractyl-health: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

InvestorRelations

InvestorRelations

Source (apis.yml)

aid: fractyl-health
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/fractyl-health.png
name: Fractyl Health
description: 'Fractyl Health, Inc. (Nasdaq: GUTS) is a clinical-stage metabolic therapeutics company developing treatments
  that target the root causes of type 2 diabetes and obesity rather than managing symptoms. Its lead product, Revita, is an
  outpatient endoscopic procedure that resurfaces the duodenal lining to address a driver of metabolic disease, and Rejuva
  is an early-stage pancreatic islet-cell gene therapy platform designed for durable, one-time metabolic remission. The company
  is headquartered in Massachusetts and backed by Bessemer Venture Partners and General Catalyst. Fractyl publishes no public
  developer API, SDK, or developer portal; this API Evangelist profile tracks its corporate, product, and investor web presence.'
url: https://raw.githubusercontent.com/api-evangelist/fractyl-health/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- bessemer-venture-partners
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Healthcare
- Biotechnology
- Metabolic Therapeutics
- Type 2 Diabetes
- Obesity
- Gene Therapy
- Medical Devices
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/fractyl-health-domain-security.yml
- type: Website
  url: https://www.fractyl.com/
- type: TermsOfService
  url: https://www.fractyl.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.fractyl.com/privacy-cookie-policy/
- type: Support
  url: https://www.fractyl.com/contact/
- type: InvestorRelations
  url: https://ir.fractyl.com/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence